Special Tuberculosis Treatment Information System (SITE-TB) in Brazil: Background, description and perspectives

11Citations
Citations of this article
17Readers
Mendeley users who have this article in their library.
Get full text

Abstract

The Special Tuberculosis Treatment Information System (SITE-TB) arose mainly from the need to routinely monitor all persons with drug-resistant tuberculosis (DR-TB) in Brazil, as well as to qualify tuberculosis’ drug control. Developed by the Professor Hélio Fraga Reference Center and the Management Sciences for Health/Brazil Project, this online system was implemented in 2013 in all Brazilian states. In addition to DR-TB, the system registers people with drug-sensitive tuberculosis with special regimen indications, and those with nontuberculous mycobacterial infections identified by differential diagnosis of tuberculosis. All confirmed tuberculosis cases should be notified on the Notifiable Diseases Information System (SINAN). In situations where treatment with special regimens is necessary, the case is closed on SINAN and notified on SITE-TB. Professionals from tuberculosis reference centers report and monitor these cases on the system, as well as manage tuberculosis’ drugs.

Cite

CITATION STYLE

APA

Bartholomay, P., Pinheiro, R. S., Pelissari, D. M., Arakaki-Sanchez, D., Dockhorn, F., Rocha, J. L., … Dalcolmo, M. (2019). Special Tuberculosis Treatment Information System (SITE-TB) in Brazil: Background, description and perspectives. Epidemiologia e Servicos de Saude, 28(2). https://doi.org/10.5123/S1679-49742019000200002

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free